Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer|DNA Damage Repair Deficiency
Interventions: DRUG: Cyclosporin A
Sponsor: Virginia G. Kaklamani